These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8832588)

  • 21. 12-O-tetradecanoylphorbol 13-acetate and forskolin modify muscarinic receptor-linked Ca2+ mobilization in SH-SY5Y neuroblastoma cells through different mechanisms.
    Akerman KE; Heikkilä JE
    J Neurochem; 1990 Feb; 54(2):497-504. PubMed ID: 2299348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic receptors coupled to phosphoinositide hydrolysis and elevated cytosolic calcium in a human neuroblastoma cell line SK-N-SH.
    Baird JG; Lambert DG; McBain J; Nahorski SR
    Br J Pharmacol; 1989 Dec; 98(4):1328-34. PubMed ID: 2558760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscarinic receptor-mediated inositol 1,4,5-trisphosphate formation in SH-SY5Y neuroblastoma cells is regulated acutely by cytosolic Ca2+ and by rapid desensitization.
    Wojcikiewicz RJ; Tobin AB; Nahorski SR
    J Neurochem; 1994 Jul; 63(1):177-85. PubMed ID: 8207426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist-induced desensitization of cholinergically stimulated phosphoinositide breakdown is independent of endogenously activated protein kinase C in HT-29 human colon carcinoma cells.
    Kopp R; Mayer P; Pfeiffer A
    Biochem J; 1990 Jul; 269(1):73-8. PubMed ID: 2165399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
    Masters SB; Quinn MT; Brown JH
    Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptamine induces phosphoinositide turnover and modulates adrenergic and muscarinic cholinergic receptor function in cultured cerebellar granule cells.
    Ishitani R; Kimura M; Takeichi M; Chuang DM
    J Neurochem; 1994 Dec; 63(6):2080-5. PubMed ID: 7964726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium-dependence of histamine- and carbachol-induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices.
    Arias-Montaño JA; Berger V; Young JM
    Br J Pharmacol; 1994 Feb; 111(2):598-608. PubMed ID: 8004403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential coupling of muscarinic receptors to Ca2+ mobilization and cyclic AMP in SH-SY5Y and IMR 32 neuroblastoma cells.
    Heikkilä J; Jansson C; Akerman KE
    Eur J Pharmacol; 1991 Sep; 208(1):9-15. PubMed ID: 1657623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyphosphoinositides are the major source of inositol phosphates in carbamoylcholine-stimulated SK-N-SH neuroblastoma cells.
    Fisher SK; Heacock AM; Seguin EB; Agranoff BW
    Mol Pharmacol; 1990 Jul; 38(1):54-63. PubMed ID: 2164631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
    Connor M; Yeo A; Henderson G
    Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epithelial phenotype of human neuroblastoma cells express bradykinin, endothelin, and angiotensin II receptors that stimulate phosphoinositide hydrolysis.
    Ogino Y; Costa T
    J Neurochem; 1992 Jan; 58(1):46-56. PubMed ID: 1309239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic receptor-stimulated phosphoinositide turnover in human SK-N-SH neuroblastoma cells: differential inhibition by agents that elevate cyclic AMP.
    Akil M; Fisher SK
    J Neurochem; 1989 Nov; 53(5):1479-86. PubMed ID: 2477499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the role of agonist-evoked Ca2+ mobilization in sustaining the ongoing phosphoinositide hydrolysis. A study on intact SK-N-BE(2) neuroblastoma cells subjected to muscarinic stimulation.
    Limatola C; Pacini L; Candi E; Spinedi A
    J Neurooncol; 1997 Jan; 31(1-2):129-32. PubMed ID: 9049839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maitotoxin induces phosphoinositide turnover and modulates glutamatergic and muscarinic cholinergic receptor function in cultured cerebellar neurons.
    Lin WW; Lee CY; Yasumoto T; Chuang DM
    J Neurochem; 1990 Nov; 55(5):1563-8. PubMed ID: 1976755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of caffeine on phosphatidylinositide turnover and calcium mobilization in human neuroblastoma SK-N-SH cells.
    Liu PS; Tu HY; Kao LS
    Chin J Physiol; 2005 Jun; 48(2):107-13. PubMed ID: 16201456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ethanol on phosphoinositide hydrolysis and muscarinic acetylcholine receptor number in SH-SY5Y cells.
    Caron M; Andersson A; Alling C
    Life Sci; 2000 Jun; 67(4):447-56. PubMed ID: 11003054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
    Fisher SK; Snider RM
    Mol Pharmacol; 1987 Jul; 32(1):81-90. PubMed ID: 3600615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by a receptor-mediated Ca2+ entry blocker, SK&F 96365, of Ca2+ and secretory responses in rat pancreatic acini.
    Busik J; Habara Y; Maruyama T; Kanno T
    Eur J Pharmacol; 1993 Nov; 247(3):273-81. PubMed ID: 7508399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex.
    Ek B; Antonsson BM
    Acta Physiol Scand; 1993 Mar; 147(3):289-95. PubMed ID: 8386426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postnatal ontogeny of agonist and depolarization-induced phosphoinositide hydrolysis in rat cerebral cortex.
    Rooney TA; Nahorski SR
    J Pharmacol Exp Ther; 1987 Oct; 243(1):333-41. PubMed ID: 2822903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.